» Articles » PMID: 35888099

Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 Jul 27
PMID 35888099
Authors
Affiliations
Soon will be listed here.
Abstract

The present investigation aims to improve the antimicrobial influence of certain antibacterial drugs, namely, neomycin (NEO), exploiting the benefits of natural oils such as tea tree oil (TTO). Therefore, a distinctive nanolipid formulation, namely, a nanoemulsion (NE), was developed using a Central Composite Factorial Design (CCD) approach depending on the amount of TTO and tween 80 as surfactant. The optimized NEO-NE formula exhibiting minimum globular size and maximum in vitro release was selected. For efficient topical delivery, NEO-NE was incorporated into a pre-formulated hydrogel. The developed NEO-NE-hydrogel was characterized by its physical characteristics such as pH, viscosity, and spreadability. Next, it was tested for stability under different conditions for 3 months. Ultimately, an irritation test was conducted followed by an antibacterial examination. The preparation demonstrated acceptable properties to be successfully applied topically. It showed non-significant changes in stability in both conditions up to 3 months storage when compared to a fresh preparation. It exhibited no irritation when applied on hairless animal skin. Finally, TTO revealed a good inhibition for the bacterial growth that could improve the influence of NEO antibacterial activity, indicating the efficiency of NE containing NEO prepared with TTO to be a promising antibacterial nanocarrier.

Citing Articles

Nanotechnological prospective for enhancing the antibacterial activity of mupirocin and cinnamon essential oil: a combination therapy.

Aldhubiab B, Almuqbil R, Shehata T, Soliman W, Elsewedy H Front Pharmacol. 2024; 15:1468374.

PMID: 39588151 PMC: 11586216. DOI: 10.3389/fphar.2024.1468374.


Formulation and Evaluation of Turmeric- and Neem-Based Topical Nanoemulgel against Microbial Infection.

Giri S, Chakraborty A, Mandal C, Rajwar T, Halder J, Irfan Z Gels. 2024; 10(9).

PMID: 39330180 PMC: 11431516. DOI: 10.3390/gels10090578.


Investigating topical delivery of erythromycin laden into lipid nanocarrier for enhancing the anti-bacterial activity.

Elsewedy H, Alshehri S, Alsammak N, Abou Chahin N, Alotaibi M, Alshammari R Saudi Pharm J. 2024; 32(9):102152.

PMID: 39165579 PMC: 11334861. DOI: 10.1016/j.jsps.2024.102152.


Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin.

Shehata T, Aldhubiab B, Elsewedy H Int J Nanomedicine. 2024; 19:7945-7961.

PMID: 39130688 PMC: 11313597. DOI: 10.2147/IJN.S463750.


Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems.

Mohseni-Motlagh S, Dolatabadi R, Baniassadi M, Baghani M Polymers (Basel). 2023; 15(22).

PMID: 38006131 PMC: 10674248. DOI: 10.3390/polym15224407.


References
1.
Yen C, Chen Y, Wu M, Wang C, Wu Y . Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. Int J Nanomedicine. 2018; 13:669-680. PMC: 5798547. DOI: 10.2147/IJN.S154824. View

2.
Zhang J, Keller K, Takemoto J, Bensaci M, Litke A, Czyryca P . Synthesis and combinational antibacterial study of 5''-modified neomycin. J Antibiot (Tokyo). 2009; 62(10):539-44. PMC: 2783947. DOI: 10.1038/ja.2009.66. View

3.
Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W . Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021; 13(24):10748-10764. DOI: 10.1039/d1nr02065j. View

4.
Bashir M, Ahmad J, Asif M, Khan S, Irfan M, Ibrahim A . Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation. Int J Nanomedicine. 2021; 16:1457-1472. PMC: 7910103. DOI: 10.2147/IJN.S294653. View

5.
Zaid Alkilani A, McCrudden M, Donnelly R . Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics. 2015; 7(4):438-70. PMC: 4695828. DOI: 10.3390/pharmaceutics7040438. View